Anna Tagliabue
Biographic Data
| ID | 7559711 |
|---|---|
| NAME | Anna Tagliabue |
| GIVEN NAMES | Anna |
| FAMILY NAME | Tagliabue |
| SIGNATURE | TAGLIABUE A |
| AFFILIATIONS | University of Pavia |
| ORCID | 0000-0002-7647-6975 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2011 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Case report
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare neurological disorder characterized by a wide spectrum of symptoms: epilepsy, movement disorders and neurocognitive impairment. The gold standard treatment for GLUT1DS are ketogenic dietary therapies (KDTs), specifically classical ketogenic diet (CKD). Despite the benefits, CKD often represents a challenge for patients and their families since meal preparation is extremely demandi…
High frequency of psychopathology in subjects wishing to lose weight
Objective To investigate the frequency of psychiatric disorders in subjects wishing to lose weight categorized according to BMI. Design Cross-sectional study. Setting An academic outpatient clinical nutrition service in Italy. Subjects A total of 207 subjects (thirty-nine men and 168 women; mean age: 38·7 ( sd 14·1) years) consecutively attending the study centre for the first time between January 2003 and December 2006. Results In the entire stu…
No prominent works on this page.
High frequency of psychopathology in subjects wishing to lose weight
Objective To investigate the frequency of psychiatric disorders in subjects wishing to lose weight categorized according to BMI. Design Cross-sectional study. Setting An academic outpatient clinical nutrition service in Italy. Subjects A total of 207 subjects (thirty-nine men and 168 women; mean age: 38·7 ( sd 14·1) years) consecutively attending the study centre for the first time between January 2003 and December 2006. Results In the entire stu…
Case report
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a rare neurological disorder characterized by a wide spectrum of symptoms: epilepsy, movement disorders and neurocognitive impairment. The gold standard treatment for GLUT1DS are ketogenic dietary therapies (KDTs), specifically classical ketogenic diet (CKD). Despite the benefits, CKD often represents a challenge for patients and their families since meal preparation is extremely demandi…
Internal Medicine (2 works) · Medicine (2 works) · Psychiatry (2 works) · Anxiety (1 works) · Clinical Psychology (1 works) · Clinical Psychology (1 works) · Cognition (1 works) · Cross-sectional study (1 works) · Diet and metabolism studies (1 works) · Diet, Metabolism, and Disease (1 works)